MktsMarkets

Vir Biotechnology, Inc.
NASDAQ: VIRKey statistics
VIR News
Stories mentioning VIR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | (29.00) | 64,070 | 240.00 | 1,214 | 3,032 | 12,374 | 2,380 | 3,075 |
| Cost of Goods Sold | 11.00 | 0.00 | 684.00 | 50.00 | 52.00 | |||
| Gross Profit | 1,203 | 3,032 | 11,690 | 2,330 | 3,023 | |||
| Operating Expenses | ||||||||
| Research & Development | 108,922 | 88,349 | 151,463 | 97,509 | 118,645 | 106,083 | 195,178 | 105,113 |
| Sales General & Admin | 23,339 | 23,616 | 22,231 | 22,283 | 23,944 | 26,701 | 25,744 | 30,265 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (132,290) | (47,921) | (173,443) | (118,417) | (139,547) | (117,150) | (231,304) | (158,630) |
| Interest Income | 7,189 | 7,802 | 9,363 | 10,785 | 12,288 | 14,153 | 17,527 | 18,846 |
| Interest Expense | ||||||||
| Other Expense | (254.00) | (335.00) | (228.00) | 226.00 | (72.00) | (506.00) | (893.00) | (535.00) |
| Pretax Income | (125,525) | (43,060) | (162,973) | (110,788) | (120,949) | (104,675) | (213,540) | (139,890) |
| Tax Provision | 170.00 | (137.00) | 168.00 | 170.00 | 16.00 | (86.00) | 177.00 | (1,512) |
| Net Income (Loss) | (125,695) | (42,923) | (163,141) | (110,958) | (120,965) | (104,589) | (213,717) | (138,378) |
| Earnings Per Share (Basic) | (0.85) | (0.31) | (1.17) | (0.80) | (0.88) | (0.77) | (1.56) | (1.02) |
| Earnings Per Share (Diluted) | (0.85) | (0.31) | (1.17) | (0.80) | (0.88) | (0.77) | (1.56) | (1.02) |
| Weighted Average Shares Outstanding (Basic) | 147,357 | 138,520 | 138,930 | 138,447 | 137,469 | 136,247 | 136,654 | 136,224 |
| Weighted Average Shares Outstanding (Diluted) | 147,357 | 138,520 | 138,930 | 138,447 | 137,469 | 136,247 | 136,654 | 136,224 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VIR
Vir Biotechnology, Inc. (NASDAQ: VIR) is a stock listed on the Nasdaq Stock Market under the ticker symbol VIR. It last traded at $10.96 (Oct 26, 2026, 3:29 PM ET), up 3.7% on the day. That gives Vir Biotechnology a market capitalisation of $1.8B.
Over the past 52 weeks VIR has traded between $4.82 and $12.00.
Revenue for the quarter ended Mar 31, 2026 was -$29.0K; a net loss of $125.7M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | -$29.0K | -$125.7M | — |
| Dec 31, 2025 | $64.1M | -$42.9M | -67.0% |
| Sep 30, 2025 | $240.0K | -$163.1M | -67975.4% |
| Jun 30, 2025 | $1.2M | -$111.0M | -9139.9% |
From Vir Biotechnology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…